In the world of diabetes technology, new advancements are constantly changing the landscape. From updated continuous glucose monitors (CGMs) and Automated Insulin Delivery (AID) systems to fully integrated apps, these innovations are transforming diabetes management and empowering people to take control with greater ease. Here’s a look at some of the latest tech developments you won’t want to miss.
Omnipod 5 App Now Available on iPhone
Exciting news for Omnipod 5 users: a new app now allows users to manage their Automated Insulin Delivery System from their iPhone. Available for free on the Apple App Store, the Omnipod 5 App enables users to perform essential functions—such as bolusing for meals, changing Pods, and adjusting settings—all from their compatible iPhone. This eliminates the need for an additional controller, simplifying the insulin management process. Currently, the app is compatible with the Dexcom G6 CGM system, with compatibility with the Dexcom G7 expected in 2025. An Android version of the app is also available for U.S. customers.
Beta Bionics iLet Bionic Pancreas to Integrate with FreeStyle Libre 3 Plus
Beta Bionics is breaking new ground with its iLet Bionic Pancreas, an innovative automated insulin delivery (AID) system. The iLet, which adapts to users’ needs without requiring carb counting or insulin corrections, will soon integrate with Abbott’s FreeStyle Libre 3 Plus CGM. This new connection will provide a streamlined, user-friendly system that calculates insulin doses based solely on the user’s weight, making setup simple and reducing the daily management burden.
Sean Saint, CEO of Beta Bionics, highlighted the company’s focus on choice and convenience: “This partnership with Abbott will enable us to offer a choice of iCGMs, so users can customize their iLet diabetes management experience with the CGM they know and trust.” This integration, expected in Q4 2024, marks the first AID integration with FreeStyle Libre 3 Plus available in the U.S., giving people with type 1 diabetes a new, intuitive option for managing their condition.
Bionic Circle App Now Live for Followers
To support the iLet Bionic Pancreas, Beta Bionics recently released the Bionic Circle app on both iPhone and Android. This app allows caregivers, family members, or friends to follow a user’s blood sugar levels, meal announcements, and insulin dosing data from anywhere. By providing real-time visibility, the app offers peace of mind for loved ones, allowing them to stay connected and offer support as needed.
Eversense 365: A Year-Long CGM Solution
Senseonics and Ascensia Diabetes Care have made headlines with the FDA approval of the Eversense 365, the world’s first CGM that lasts a full year. With only one insertion needed per year, this fully implantable CGM offers a more sustainable and manageable solution for people with diabetes.
Cleared as an integrated CGM (iCGM), the Eversense 365 is designed to pair with insulin pumps as part of automated insulin delivery (AID) systems. Ascensia aims to launch this innovative solution in late 2024 and is actively working on expanding insurance coverage for broader accessibility.
SweetSpot offers comprehensive solution for diabetes practices paired with end-to-end clinical support
Software platforms are vital for integrating and analyzing data from CGMs, insulin pumps, and other diabetes management tools – especially as more are added to the market. SweetSpot, for example, offers a comprehensive solution that empowers healthcare practices to gain deeper insights into their patients’ glycemic health. SweetSpot consolidates data from patients across all major CGMs and insulin devices, allowing providers to easily view all this information in one place instead of sifting through multiple portals.
The SweetSpot team consists of physicians, endocrinologists, and Certified Diabetes Care and Education Specialists who stay at the forefront of innovations in diabetes technology. They are dedicated to making all data accessible and actionable, offering personalized insights to support better patient outcomes at practices they partner with.
As innovations in diabetes technology continue to grow, SweetSpot will keep integrating with even more devices to enhance the scope and ease of diabetes care. Stay tuned as more advancements continue to shape the future of diabetes technology.
Want to learn more about SweetSpot and how we are revolutionizing diabetes management? Check out our website or shoot us a message at info@sweetspot.health.
SweetSpot is a remote diabetes management platform that supports all major diabetes devices and insulin delivery systems to provide physicians with a single view of their patients’ data. SweetSpot's intelligent algorithm identifies the most optimal CPT codes for both remote and in-person diabetes management, and a dedicated team of Certified Diabetes Care & Education Specialists provide ongoing support.
As a company founded and powered by physicians and diabetes care providers, we place a strong emphasis on ensuring that there are no obstacles to getting started with SweetSpot. That’s why SweetSpot is easy to set up and designed to seamlessly integrate into your existing workflows and comes with no setup costs or subscription fees.
Bình luận